Brand & Specialty

Brand & Specialty Products

Mylan operates as two business entities in Canada to deliver high quality medicine: Mylan Pharmaceuticals ULC, which markets primarily generic products, and BGP Pharma ULC, acquired by Mylan in February 2015 and doing business as Mylan EPD, which markets predominantly specialty medicines. See the full list of products marketed in Canada below.

Brand & Specialty products offered by Mylan Pharmaceuticals ULC

  • Mylan-Dexrazoxane
    250 mg powder for
    Injection (US-labelled)

    Due to a shortage in Canada, Pfizer Canada ULC has informed Health Canada that a steady supply of its ZINECARD (Dexrazoxane for Injection) is not expected until January 31, 2021. Given the medical necessity of this product, Health Canada has expressed no objection to the temporary importation and distribution of US-labelled Mylan-Dexrazoxane for Injection.

    Important Safety Information

    US-labelled Mylan Dexrazoxane Prescribing Information

  • PrGen-Clozapine

    Health Canada has deemed Gen-Clozapine bioequivalent to Clozaril®.  Demonstrating Mylan’s commitment to patient safety, GenCAN is a national network designed to assist physicians and pharmacists in the registering and monitoring of Gen-Clozapine patients

  • Clarus®

    Health Canada has deemed Clarus® bioequivalent to Accutane®.  The Clarus® CLEAR™ Program provides information and support materials for Clarus®

    patients and healthcare professionals, such as pregnancy prevention checklists, patient monitoring charts, blood monitoring guides and patient reminder slips.

Brand & Specialty products offered by Mylan EPD

  • Questions?

    Get more information on our products, services and Mylan Global Center locations.
    Contact us

  • Business Opportunities

    Do you have an opportunity or a collaboration idea?
    Partner with us